Literature DB >> 2295339

Follicular fluid Lidocaine levels during transvaginal oocyte retrieval.

D D Bailey-Pridham1, E Reshef, K Drury, C L Cook, H E Hurst, M A Yussman.   

Abstract

Lidocaine has been shown to have adverse effects on mouse oocyte fertilization and embryo development. We have demonstrated the presence of pharmacologic levels of lidocaine in human serum and follicular fluid obtained during ultrasound guided transvaginal oocyte retrieval. The significance of this finding is unclear, as four of the eight patients studied became pregnant, including the patient with the highest follicular fluid lidocaine levels. Further evaluation of the effect of lidocaine on human embryos is warranted.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2295339     DOI： 10.1016/s0015-0282(16)53237-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  4 in total

1.  The effects of lignocaine on human sperm motility.

Authors:  S J Bennett; V Bolton; J Parsons
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

2.  A randomized double-blind study to compare the effectiveness of three different doses of lignocaine used in paracervical block during oocyte retrieval.

Authors:  Ernest Hung Yu Ng; Benyu Miao; Pak Chung Ho
Journal:  J Assist Reprod Genet       Date:  2003-01       Impact factor: 3.412

3.  Effect of Body Mass Index on the Efficacy of Paracervical Block for Ultrasound-Guided Transvaginal Oocyte Retrieval as assessed by Requirement of Rescue Propofol.

Authors:  Dipti Saxena; Rajeev Rai; Atul Dixit; Shilpa Bhandari; Sadhana Sanwatsarkar
Journal:  J Hum Reprod Sci       Date:  2018 Oct-Dec

4.  Comparison of Two Different Sedation Protocols during Transvaginal Oocyte Retrieval: Effects on Propofol Consumption and IVF Outcome: A Prospective Cohort Study.

Authors:  Paraskevi Matsota; Tatiana Sidiropoulou; Tereza Vrantza; Maria Boutsikou; Elena Midvighi; Charalampos Siristatidis
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.